Efgartigimod demonstrated superior efficacy over IVIG in improving MG-ADL and QMG scores in myasthenia gravis patients. Patients treated with efgartigimod experienced faster symptom improvement and ...

If you have an immunodeficiency related to certain infections, inflammatory diseases, or autoimmune disorders, you may have heard about an infusion treatment called intravenous immunoglobulin, or IVIG ...

It is normal for the immune system to make antibodies to fight bacterial or viral infections. Nearly everyone has a pool of antibodies circulating in their blood ready to go to battle should there be ...

Myasthenia gravis is a rare disease where the immune system attacks the communication between nerves and muscles, causing weakness. It often affects the muscles used for eye movement, facial ...

IVIG has been used to treat AIN, but it is not always effective. We report a patient in which the concommitant use of IVIG and steroid was more effective than either alone. A 10 year old girl with ...

Preterm newborns are susceptible of invasion by microorganisms due to immaturity of their immune system. This study aimed at assessing the effect of IV immunoglobulins as supportive treatment in ...

"I realized there were a lot of other people across the country doing the same thing I was. So I figured I could connect with ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Some IVIG brands, like Gammagard, contain added sugar. This could cause your blood glucose to rise temporarily. But studies don’t show weight gain as a typical side effect of IVIG. Intravenous ...

Treatments for myasthenia gravis include medications to help control and prevent symptoms related to muscle weakness and ...

Journal Scan is the clinician's guide to the latest clinical research findings in Annals of Neurology, Neurology, Archives of Neurology, Archives of Neurosurgery, The Lancet, The New England Journal ...